772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy

BackgroundMelanoma is an increasing public health concern. Immune checkpoint inhibitors (ICI) has revolutionized the treatment of advanced melanoma. Unfortunately, in the adjuvant setting, up to 30% of subjects have disease recurrence within 1 year of treatment. Previous studies have shown that subj...

Full description

Saved in:
Bibliographic Details
Published inJournal for immunotherapy of cancer Vol. 11; no. Suppl 1; pp. A867 - A869
Main Authors Doonan, Bently, Shaw, Christiana, Lee, Ji-Hyun, Manso, Eugenio, Mendez-Gomez, Hector, Roemeling, Christina Von, Mitchell, Duane A, Sayour, Elias
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.11.2023
BMJ Publishing Group LTD
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…